Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-11-27
1989-08-15
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, 514395, 548305, 548329, 548330, A61K 31415
Patent
active
048575402
ABSTRACT:
1-substituted-2-mercapto(or aminomethyl)benzimidazole compounds which inhibit dopamine-.beta.-hydroxylase activity.
REFERENCES:
Tyurenkova et al., Khim Geterotsikl. Soedin, 1980, No. 6, pp. 818-821.
Bianchi et al., Eur. J. Med. Chem., 1981, vol. 16, No. 4, pp. 321-326.
Chemical Abstracts, vol. 58, No. 12, Abstract No. 139644, Jun. 10, 1963 (Nakajima et al.).
Chemical Abstracts, vol. 69, No. 22, Abstract No. 96573r, Nov. 25, 1968 (Aryuzina et al.).
Kaiser Carl
Kruse Lawrence I.
Lee Mary C.
Lourie Alan D.
Northington Zinna
SmithKline Beckman Corporation
Suter Stuart R.
LandOfFree
Dopamine-.beta.-hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine-.beta.-hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine-.beta.-hydroxylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121946